Literature DB >> 22537820

Quantification of Pseudomonas aeruginosa hydrogen cyanide production by a polarographic approach.

Anne-Sophie Blier1, Julien Vieillard, Eloïse Gerault, Audrey Dagorn, Tony Varacavoudin, Franck Le Derf, Nicole Orange, Marc Feuilloley, Olivier Lesouhaitier.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen responsible for numerous infections acquired in hospital especially in persons whose immune systems are weakened, such as with patient suffering from AIDS or cystic fibrosis. This bacterium produces a great diversity of virulence factors among them hydrogen cyanide (HCN) which is one of the most potent and toxic. A precise quantification of HCN or CN(-) ion is essential to understand the involvement of this toxin in the pathogenesis of P. aeruginosa. In the present study, we present a new technique based on a polarographic approach to measure the production kinetics of HCN/CN(-) by P. aeruginosa strains, in several media commonly used in microbiology labs. The method was validated using mutants (hcnB- and hcnC-) which are unable to produce detectable HCN/CN(-). The kinetics of HCN/CN(-) production by P. aeruginosa in Luria Bertani (LB) medium showed a parabolic shape with a peak observed at 4, 5 and 8h for strains PA14, PAO1 and MPAO1, respectively. When bacteria were grown in ordinary nutrient broth (ONB) 2.5% medium, a less adapted medium for bacterial growth, the general profile of the kinetics was conserved but peak production was delayed (10 and 12h for PAO1 and MPAO1, respectively). When the bacteria were cultured in minimum medium MMC, bacterial growth was particularly slow and HCN/CN(-) production was markedly reduced. Taken together, this new polarographic method appears as a useful technique to detect and quantify HCN/CN(-) in routine media where the bacteria can express and regulate high amounts of toxins. With this method, we demonstrate that HCN/CN(-) production by P. aeruginosa is maximal at the end of the exponential growth phase and depends on the richness of the growth medium used.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537820     DOI: 10.1016/j.mimet.2012.04.005

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  5 in total

Review 1.  Resistance Is Not Futile: The Role of Quorum Sensing Plasticity in Pseudomonas aeruginosa Infections and Its Link to Intrinsic Mechanisms of Antibiotic Resistance.

Authors:  Kayla A Simanek; Jon E Paczkowski
Journal:  Microorganisms       Date:  2022-06-18

2.  The aliphatic amidase AmiE is involved in regulation of Pseudomonas aeruginosa virulence.

Authors:  Thomas Clamens; Thibaut Rosay; Alexandre Crépin; Teddy Grandjean; Takfarinas Kentache; Julie Hardouin; Perrine Bortolotti; Anke Neidig; Marlies Mooij; Mélanie Hillion; Julien Vieillard; Pascal Cosette; Joerg Overhage; Fergal O'Gara; Emeline Bouffartigues; Alain Dufour; Sylvie Chevalier; Benoit Guery; Pierre Cornelis; Marc G J Feuilloley; Olivier Lesouhaitier
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

3.  Genome Comparison of Pseudomonas fluorescens UM270 with Related Fluorescent Strains Unveils Genes Involved in Rhizosphere Competence and Colonization.

Authors:  Julie E Hernández-Salmerón; Gabriel Moreno-Hagelsieb; Gustavo Santoyo
Journal:  J Genomics       Date:  2017-08-24

4.  SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients.

Authors:  Rikke Kragh Lauridsen; Lea M Sommer; Helle Krogh Johansen; Tomas Rindzevicius; Søren Molin; Lars Jelsbak; Søren Balling Engelsen; Anja Boisen
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

5.  Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa.

Authors:  Nikola Strempel; Anke Neidig; Michael Nusser; Robert Geffers; Julien Vieillard; Olivier Lesouhaitier; Gerald Brenner-Weiss; Joerg Overhage
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.